Online ISSN: 1945-4589

Adipogenic progenitors keep muscle stem cells young

10-03-2019

In adult skeletal muscle, loss of myofiber integrity caused by mechanical injuries or diseases are repaired by resident muscle stem cells, called satellite cells, which promptly exit from quiescence after disruption of muscle architecture to expand, differentiate and drive tissue regeneration.

Dr. Jerome N. Feige from Nestlé Research, EPFL Innovation Park, Lausanne, Switzerland said, "Fibro/adipogenic progenitors constitute a population of interstitial mesenchymal cells in skeletal muscle which are devoid of myogenic potential, but support muscle stem cell commitment and can differentiate to the adipogenic or fibrotic lineages."

Thus, FAPs are active regulators of cellular communication in skeletal muscle niche where they directly control tissue homeostasis and regeneration by supporting Mu SCs and myofibers.

In a recent study, the author’s lab investigated how aging influences the fate of FAPs and their cross-talk with Mu SCs to regulate the balance between myogenesis, adipogenesis and fibrosis in skeletal muscle.

Interestingly, aged FAPs fail to efficiently amplify following muscle injury and aging alters the capacity of FAPs to support Mu SC amplification and commitment.

Both in-vitro co-culture and in-vivo transplantation of young FAPs rejuvenate aged Mu SC function, but aged FAPs lose the ability to efficiently support Mu SCs.

The Feige Research team concluded, "FAPs are also likely a heterogeneous population and the clonal selection of different fates of FAPs during aging suggests a differential effect of age on distinct subpopulations.

While Tie2- expressing FAPs predominantly reside within neonatal and adult homeostatic muscles, another injury-activated subpopulation of FAPs characterized by Vcam1 expression is associated with regeneration of injured myofibers."

Full Text - https://www.aging-us.com/article/102304/text

Correspondence to: Jerome N. Feige email: Jerome.feige@rd.nestle.com

Keywords: muscle stem cell, regeneration, aging, fibro/adipogenic progenitor, niche

About Aging-US:

Aging publishes research papers in all fields of aging research including but not limited, aging from yeast to mammals, cellular senescence, age-related diseases such as cancer and Alzheimer’s diseases and their prevention and treatment, anti-aging strategies and drug development and especially the role of signal transduction pathways such as mTOR in aging and potential approaches to modulate these signaling pathways to extend lifespan. The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases, prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.

Aging is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed Central, Web of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Please visit our website at www.Aging-US.com and connect with us:

For media inquiries, please contact media@impactjournals.com.